In vivo roles for myosin phosphatase targeting subunit-1 phosphorylation sites T694 and T852 in bladder smooth muscle contraction

Journal of Physiology

Volumn 593, Issue 3, 2015, Pages 681-700

  Chen, Cai Ping ^a   Chen, Xin ^a   Qiao, Yan Ning ^b   Wang, Pei ^a   He, Wei Qi ^a   Zhang, Cheng Hai ^a   Zhao, Wei ^a   Gao, Yun Qian ^a   Chen, Chen ^a   Tao, Tao ^a   Sun, Jie ^a   Wang, Ye ^a   Gao, Ning ^c   Kamm, Kristine E ^c   Stull, James T ^c   Zhu, Min Sheng ^a,d  

^a NANJING UNIVERSITY   (China)

^b SHAANXI NORMAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d Beijing Collaborative Innovation Center for Cardiovascular Disorders   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COFILIN; F ACTIN; G PROTEIN COUPLED RECEPTOR; LIM KINASE 1; MYOSIN LIGHT CHAIN PHOSPHATASE; MYOSIN PHOSPHATASE TARGETING SUBUNIT 1; UNCLASSIFIED DRUG; MYOSIN LIGHT CHAIN KINASE; PPP1R12A PROTEIN, MOUSE;

ANIMAL TISSUE; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BINDING AFFINITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE LOCUS; GENOTYPE; HETEROZYGOSITY; HOMOLOGOUS RECOMBINATION; IN VIVO STUDY; MORPHOGENESIS; MOUSE; MUSCLE CONTRACTION; NONHUMAN; POINT MUTATION; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; ANIMAL; BLADDER; C57BL MOUSE; CHEMISTRY; CYTOLOGY; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYOSIN-LIGHT-CHAIN KINASE; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; POINT MUTATION; URINARY BLADDER;

EID: 84921895781     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.283853     Document Type: Article

References (91)

1. Alessi D, MacDougall LK, Sola MM, Ikebe M & Cohen P (1992). The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1. Eur J Biochem 210, 1023-1035.
2. Amano M, Fukata Y & Kaibuchi K (2000). Regulation and functions of Rho-associated kinase. Exp Cell Res 261, 44-51.
3. 2+ sensitization pathways accessed by cholinergic neurotransmission in the murine gastric fundus. J Physiol 591, 2971-2986.
4. Butler T, Paul J, Europe-Finner N, Smith R & Chan EC (2013). Role of serine-threonine phosphoprotein phosphatases in smooth muscle contractility. Am J Physiol Cell Physiol 304, C485-C504.
5. 2+-independent MLCK activity in hypertensive rats. Cardiovasc Res 91, 162-170.
6. Dauve V & McLin VA (2013). Recent advances in the molecular and genetic understanding of congenital gastrointestinal malformations. J Pediatr Gastroenterol Nutr 57, 4-13.
7. 2+ sensitization of contraction in arterial smooth muscle. Circ Res 100, 121-129.
8. 2+ sensitivity, and myosin light chain phosphorylation in urinary bladder smooth muscle of newborn mice. J Gen Physiol 125, 187-196.
9. Eto M, Kitazawa T & Brautigan DL (2004). Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits. Proc Natl Acad Sci USA 101, 8888-8893.
10. Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ & Nakano T (1999). Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274, 37385-37390.
11. Fernandes LB, Henry PJ & Goldie RG (2007). Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease. Ther Adv Respir Dis 1, 25-33.
12. Fonseca C, Abraham D & Ponticos M (2009). Neuronal regulators and vascular dysfunction in Raynaud's phenomenon and systemic sclerosis. Curr Vasc Pharmacol 7, 34-39.
13. Fu K, Mende Y, Bhetwal BP, Baker S, Perrino BA, Wirth B & Fisher SA (2012). Tra2β is required for tissue-specific splicing of a smooth muscle myosin phosphatase targeting subunit alternative exon. J Biol Chem 287, 16575-16585.
14. Fukumoto Y & Shimokawa H (2013). Rho-kinase inhibitors. Handb Exp Pharmacol 218, 351-363.
15. Gao N, Huang J, He W, Zhu M, Kamm KE & Stull JT (2013). Signaling through myosin light chain kinase in smooth muscles. J Biol Chem 288, 7596-7605.
16. Garay RP (2000). Cellular mechanisms of smooth muscle contraction. Rev Mal Respir 17, 531-533.
17. Ghisdal P, Vandenberg G & Morel N (2003). Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries. J Physiol 551, 855-867.
18. Grassie ME, Moffat LD, Walsh MP & MacDonald JA (2011). The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ. Arch Biochem Biophys 510, 147-159.
19. Gunst SJ & Zhang W (2008). Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. Am J Physiol Cell Physiol 295, C576-C587.
20. Gutzman JH & Sive H (2010). Epithelial relaxation mediated by the myosin phosphatase regulator Mypt1 is required for brain ventricle lumen expansion and hindbrain morphogenesis. Development 137, 795-804.
21. Hartshorne DJ, Ito M & Erdodi F (2004). Role of protein phosphatase type 1 in contractile functions: myosin phosphatase. J Biol Chem 279, 37211-37214.
22. He WQ, Peng YJ, Zhang WC, Lv N, Tang J, Chen C, Zhang CH, Gao S, Chen HQ, Zhi G, Feil R, Kamm KE, Stull JT, Gao X & Zhu MS (2008). Myosin light chain kinase is central to smooth muscle contraction and required for gastrointestinal motility in mice. Gastroenterology 135, 610-620.
23. He WQ, Qiao YN, Peng YJ, Zha JM, Zhang CH, Chen C, Chen CP, Wang P, Yang X, Li CJ, Kamm KE, Stull JT & Zhu MS (2013). Altered contractile phenotypes of intestinal smooth muscle in mice deficient in myosin phosphatase target subunit 1. Gastroenterology 144, 1456-1465, 1465 e1451-e1455.
24. He WQ, Qiao YN, Zhang CH, Peng YJ, Chen C, Wang P, Gao YQ, Chen C, Chen X, Tao T, Su XH, Li CJ, Kamm KE, Stull JT & Zhu MS (2011). Role of myosin light chain kinase in regulation of basal blood pressure and maintenance of salt-induced hypertension. Am J Physiol Heart Circ Physiol 301, H584-H591.
25. Henson JH, Kolnik SE, Fried CA, Nazarian R, McGreevy J, Schulberg KL, Detweiler M & Trabosh VA (2003). Actin-based centripetal flow: phosphatase inhibition by calyculin-A alters flow pattern, actin organization, and actomyosin distribution. Cell Motil Cytoskeleton 56, 252-266.
26. Hermsmeyer K, Sturek M & Rusch NJ (1988). Calcium channel modulation by dihydropyridines in vascular smooth muscle. Ann NY Acad Sci 522, 25-31.
27. Hirano K, Chartier L, Taylor RG, Allen RE, Fusetani N, Karaki H & Hartshorne DJ (1992). Changes in the cytoskeleton of 3T3 fibroblasts induced by the phosphatase inhibitor, calyculin-A. J Muscle Res Cell Motil 13, 341-353.
28. Huang H, Ruan H, Aw MY, Hussain A, Guo L, Gao C, Qian F, Leung T, Song H, Kimelman D, Wen Z & Peng J (2008). Mypt1-mediated spatial positioning of Bmp2-producing cells is essential for liver organogenesis. Development 135, 3209-3218.
29. Hudson CA, Heesom KJ & Lopez Bernal A (2012). Phasic contractions of isolated human myometrium are associated with Rho-kinase (ROCK)-dependent phosphorylation of myosin phosphatase-targeting subunit (MYPT1). Mol Hum Reprod 18, 265-279.
30. Hypolite JA, Lei Q, Chang S, Zderic SA, Butler S, Wein AJ, Malykhina AP & Chacko S (2013). Spontaneous and evoked contractions are regulated by PKC-mediated signaling in detrusor smooth muscle: involvement of BK channels. Am J Physiol Renal Physiol 304, F451-F462.
31. Ichikawa K, Ito M & Hartshorne DJ (1996). Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity. J Biol Chem 271, 4733-4740.
32. Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D & et al. (1989). Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159, 871-877.
33. Ito M, Nakano T, Erdodi F & Hartshorne DJ (2004). Myosin phosphatase: structure, regulation and function. Mol Cell Biochem 259, 197-209.
34. Kamm KE & Stull JT (1985). The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25, 593-620.
35. Kamm KE & Stull JT (2001). Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 276, 4527-4530.
36. Kawano Y, Fukata Y, Oshiro N, Amano M, Nakamura T, Ito M, Matsumura F, Inagaki M & Kaibuchi K (1999). Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol 147, 1023-1038.
37. Khasnis M, Nakatomi A, Gumpper K & Eto M (2014). Reconstituted human myosin light chain phosphatase reveals distinct roles of two inhibitory phosphorylation sites of the regulatory subunit, MYPT1. Biochemistry 53, 2701-2709.
38. 2+ sensitization force of smooth muscle contraction. J Biol Chem 284, 21569-21579.
39. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A & Kaibuchi K (1996). Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273, 245-248.
40. Kiss A, Lontay B, Becsi B, Markasz L, Olah E, Gergely P & Erdodi F (2008). Myosin phosphatase interacts with and dephosphorylates the retinoblastoma protein in THP-1 leukemic cells: its inhibition is involved in the attenuation of daunorubicin-induced cell death by calyculin-A. Cell Signal 20, 2059-2070.
41. 2+-sensitization of CPI-17 phosphorylation in arterial smooth muscle. Biochem Biophys Res Commun 401, 75-78.
42. Kitazawa T, Eto M, Woodsome TP & Brautigan DL (2000). Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275, 9897-9900.
43. 2+ sensitization in rabbit smooth muscle. J Physiol 546, 879-889.
44. Liu P, Jenkins NA & Copeland NG (2003). A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res 13, 476-484.
45. MacDonald JA, Borman MA, Muranyi A, Somlyo AV, Hartshorne DJ & Haystead TA (2001). Identification of the endogenous smooth muscle myosin phosphatase-associated kinase. Proc Natl Acad Sci USA 98, 2419-2424.
46. Maki J, Hirano M, Hoka S, Kanaide H & Hirano K (2010). Involvement of reactive oxygen species in thrombin-induced pulmonary vasoconstriction. Am J Respir Crit Care Med 182, 1435-1444.
47. Matsumura F & Hartshorne DJ (2008). Myosin phosphatase target subunit: many roles in cell function. Biochem Biophys Res Commun 369, 149-156.
48. Meng NH, Lo SF, Chou LW, Yang PY, Chang CH & Chou EC (2010). Erratum: Incomplete bladder emptying in patients with stroke: is detrusor external sphincter dyssynergia a potential cause? Arch Phys Med Rehab 91, 1793.
49. Moosmang S, Schulla V, Welling A, Feil R, Feil S, Wegener JW, Hofmann F & Klugbauer N (2003). Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J 22, 6027-6034.
50. 2+ sensitization due to myosin light chain phosphatase inhibition and cytoskeletal reorganization in the myogenic response of skeletal muscle resistance arteries. J Physiol 591, 1235-1250.
51. Moreno-Dominguez A, El-Yazbi AF, Zhu HL, Colinas O, Zhong XZ, Walsh EJ, Cole DM, Kargacin GJ, Walsh MP & Cole WC (2014). Cytoskeletal reorganization evoked by Rho-associated kinase- and protein kinase C-catalyzed phosphorylation of cofilin and heat shock protein 27, respectively, contributes to myogenic constriction of rat cerebral arteries. J Biol Chem 289, 20939-20952.
52. 2+ sensitization in intestinal smooth muscle. Neurogastroenterol Motil 23, 1111-1122.
53. Muranyi A, Derkach D, Erdodi F, Kiss A, Ito M & Hartshorne DJ (2005). Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells. FEBS Lett 579, 6611-6615.
54. Muranyi A, MacDonald JA, Deng JT, Wilson DP, Haystead TA, Walsh MP, Erdodi F, Kiss E, Wu Y & Hartshorne DJ (2002). Phosphorylation of the myosin phosphatase target subunit by integrin-linked kinase. Biochem J 366, 211-216.
55. Nakamura K, Koga Y, Sakai H, Homma K & Ikebe M (2007). cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase. Circ Res 101, 712-722.
56. Neppl RL, Lubomirov LT, Momotani K, Pfitzer G, Eto M & Somlyo AV (2009). Thromboxane A2-induced bi-directional regulation of cerebral arterial tone. J Biol Chem 284, 6348-6360.
57. Niiro N, Koga Y & Ikebe M (2003). Agonist-induced changes in the phosphorylation of the myosin-binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle. Biochem J 369, 117-128.
58. Ohama T, Hori M & Ozaki H (2007). Mechanism of abnormal intestinal motility in inflammatory bowel disease: how smooth muscle contraction is reduced? J Smooth Muscle Res 43, 43-54.
59. Okamoto R, Ito M, Suzuki N, Kongo M, Moriki N, Saito H, Tsumura H, Imanaka-Yoshida K, Kimura K, Mizoguchi A, Hartshorne DJ & Nakano T (2005). The targeted disruption of the MYPT1 gene results in embryonic lethality. Transgenic Res 14, 337-340.
60. Qiao YN, He WQ, Chen CP, Zhang CH, Zhao W, Wang P, Zhang L, Wu YZ, Yang X, Peng YJ, Gao JM, Kamm KE, Stull JT & Zhu MS (2014). Myosin phosphatase target subunit 1 (MYPT1) regulates the contraction and relaxation of vascular smooth muscle and maintains blood pressure. J Biol Chem 289, 22512-22523.
61. Sakai H, Chiba Y & Misawa M (2007). Role of Rho kinase in endothelin-1-induced phosphorylation of CPI-17 in rat bronchial smooth muscle. Pulm Pharmacol Ther 20, 734-739.
62. Satoh K, Fukumoto Y & Shimokawa H (2011). Rho-kinase: important new therapeutic target in cardiovascular diseases. Am J Physiol Heart Circ Physiol 301, H287-H296.
63. Shimizu Y, Thumkeo D, Keel J, Ishizaki T, Oshima H, Oshima M, Noda Y, Matsumura F, Taketo MM & Narumiya S (2005). ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles. J Cell Biol 168, 941-953.
64. Shirazi A, Iizuka K, Fadden P, Mosse C, Somlyo AP, Somlyo AV & Haystead TA (1994). Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. The differential effects of the holoenzyme and its subunits on smooth muscle. J Biol Chem 269, 31598-31606.
65. Somlyo AP & Somlyo AV (2000). Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522, 177-185.
66. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83, 1325-1358.
67. Stav K, Shilo Y, Zisman A, Lindner A & Leibovici D (2013). Comparison of lower urinary tract symptoms between women with detrusor overactivity and impaired contractility, and detrusor overactivity and preserved contractility. J Urol 189, 2175-2178.
68. Takizawa N, Koga Y & Ikebe M (2002). Phosphorylation of CPI17 and myosin binding subunit of type 1 protein phosphatase by p21-activated kinase. Biochem Biophys Res Commun 297, 773-778.
69. Tanaka J, Ito M, Feng J, Ichikawa K, Hamaguchi T, Nakamura M, Hartshorne DJ & Nakano T (1998). Interaction of myosin phosphatase target subunit 1 with the catalytic subunit of type 1 protein phosphatase. Biochemistry 37, 16697-16703.
70. Terrak M, Kerff F, Langsetmo K, Tao T & Dominguez R (2004). Structural basis of protein phosphatase 1 regulation. Nature 429, 780-784.
71. Thumkeo D, Shimizu Y, Sakamoto S, Yamada S & Narumiya S (2005). ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo. Genes Cells 10, 825-834.
72. Totsukawa G, Yamakita Y, Yamashiro S, Hosoya H, Hartshorne DJ & Matsumura F (1999). Activation of myosin phosphatase targeting subunit by mitosis-specific phosphorylation. J Cell Biol 144, 735-744.
73. Trinkle-Mulcahy L, Ichikawa K, Hartshorne DJ, Siegman MJ & Butler TM (1995). Thiophosphorylation of the 130-kDa subunit is associated with a decreased activity of myosin light chain phosphatase in α-toxin-permeabilized smooth muscle. J Biol Chem 270, 18191-18194.
74. Tsai MH, Chang AN, Huang J, He W, Sweeney HL, Zhu M, Kamm KE & Stull JT (2014). Constitutive phosphorylation of myosin phosphatase targeting subunit-1 in smooth muscle. J Physiol 592, 3031-3051.
75. Tsai MH, Kamm KE & Stull JT (2012). Signalling to contractile proteins by muscarinic and purinergic pathways in neurally stimulated bladder smooth muscle. J Physiol 590, 5107-5121.
76. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M & Narumiya S (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-994.
77. Velasco G, Armstrong C, Morrice N, Frame S & Cohen P (2002). Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1 M at Thr850 induces its dissociation from myosin. FEBS Lett 527, 101-104.
78. Vesterinen HM, Currie GL, Carter S, Mee S, Watzlawick R, Egan KJ, Macleod MR & Sena ES (2013). Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke. Syst Rev 2, 33.
79. Walsh MP & Cole WC (2013). The role of actin filament dynamics in the myogenic response of cerebral resistance arteries. J Cereb Blood Flow Metab 33, 1-12.
80. Wang T, Kendig DM, Chang S, Trappanese DM, Chacko S & Moreland RS (2012). Bladder smooth muscle organ culture preparation maintains the contractile phenotype. Am J Physiol Renal Physiol 303, F1382-F1397.
81. Wang T, Kendig DM, Smolock EM & Moreland RS (2009). Carbachol-induced rabbit bladder smooth muscle contraction: roles of protein kinase C and Rho kinase. Am J Physiol Renal Physiol 297, F1534-F1542.
82. Wooldridge AA, MacDonald JA, Erdodi F, Ma C, Borman MA, Hartshorne DJ & Haystead TA (2004). Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of serine 695 in response to cyclic nucleotides. J Biol Chem 279, 34496-34504.
83. Wynne BM, Chiao CW & Webb RC (2009). Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1. J Am Soc Hypertens 3, 84-95.
84. Xia D, Stull JT & Kamm KE (2005). Myosin phosphatase targeting subunit 1 affects cell migration by regulating myosin phosphorylation and actin assembly. Exp Cell Res 304, 506-517.
85. Yamashiro S, Yamakita Y, Totsukawa G, Goto H, Kaibuchi K, Ito M, Hartshorne DJ & Matsumura F (2008). Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing polo-like kinase 1. Dev Cell 14, 787-797.
86. Yokoyama T, Goto H, Izawa I, Mizutani H & Inagaki M (2005). Aurora-B and Rho-kinase/ROCK, the two cleavage furrow kinases, independently regulate the progression of cytokinesis: possible existence of a novel cleavage furrow kinase phosphorylates ezrin/radixin/moesin (ERM). Genes Cells 10, 127-137.
87. Yuen S, Ogut O & Brozovich FV (2011). MYPT1 protein isoforms are differentially phosphorylated by protein kinase G. J Biol Chem 286, 37274-37279.
88. Zagorska A, Deak M, Campbell DG, Banerjee S, Hirano M, Aizawa S, Prescott AR & Alessi DR (2010). New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion. Sci Signal 3, ra25.
89. Zderic SA & Chacko S (2012). Alterations in the contractile phenotype of the bladder: lessons for understanding physiological and pathological remodelling of smooth muscle. J Cell Mol Med 16, 203-217.
90. Zhang WC, Peng YJ, Zhang GS, He WQ, Qiao YN, Dong YY, Gao YQ, Chen C, Zhang CH, Li W, Shen HH, Ning W, Kamm KE, Stull JT, Gao X & Zhu MS (2010). Myosin light chain kinase is necessary for tonic airway smooth muscle contraction. J Biol Chem 285, 5522-5531.
91. Zhou Q, Gensch C & Liao JK (2011). Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease. Trends Pharmacol Sci 32, 167-173.